检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王冰[1] 王泉[1] 隋晓晶 李进峰 崔瑛洁 张媛[1] Wang Bing;Wang Quan;Sui Xiaojing;Li Jinfeng;Cui Yingjie;Zhang Yuan(Department of Pharmacy,Weihai Municipal Hospital,Cheeloo College of Medicine,Shandong University,Shandong Province,Weihai 264200,China)
机构地区:[1]山东大学附属威海市立医院药剂科,威海264200
出 处:《药物不良反应杂志》2024年第10期636-638,共3页Adverse Drug Reactions Journal
摘 要:1例67岁男性食管癌患者接受信迪利单抗+化疗[信迪利单抗注射液200 mg静脉滴注、化疗前1天+紫杉醇(白蛋白结合型)200 mg静脉滴注第1天、300 mg第5天+奈达铂静脉滴注80 mg第1天、70 mg第2天,21 d为1个周期],共治疗4个周期。此后因出现纵膈淋巴结转移,接受信迪利单抗+姑息性放疗1次,8 d后出现尿频、尿急、尿痛,尿常规示红细胞638个/μl、白细胞2141个/μl,结核杆菌感染T细胞检测结果阳性,膀胱镜检查示膀胱黏膜弥漫性红肿,诊断为免疫相关性膀胱炎和膀胱结核,考虑与信迪利单抗有关。予甲泼尼龙琥珀酸钠和抗结核治疗。治疗5 d后患者前述症状缓解,尿常规恢复正常。此后未再使用信迪利单抗,患者未再出现相关症状。A 67-year-old male patient with esophageal cancer received sintilimab and chemotherapy[sintilimab injection 200 mg by IV infusion,1 day before chemotherapy,paclitaxel(albumin bound)200 mg by IV infusion on day 1 and 300 mg on day 5,and nedaplatin 80 mg by IV infusion on day 1 and 70 mg on day 2,21 days as 1 cycle]for 4 cycles.Later,due to mediastinal lymph node metastasis,the patient received sintilimab and palliative radiotherapy one time.Eight days later,the patient developed urinary frequency,urgency and pain,urine routine showed 638 red blood cells/μl,and 2141 white blood cells/μl.The T-cell test for mycobacterium tuberculosis infection was positive,and cystoscopy showed diffuse redness and swell-ing of bladder mucosa.The patient was diagnosed with immune-related cystitis and bladder tuberculosis,which was considered to be related to sintilimab.Methylprednisolone sodium succinate and anti-tuberculosis treatment were given.After 5 days of treatments,the patient′s aforementioned symptoms were improved and the urine routine returned to normal.Afterwards,sintilimab was not used again and relevant symptoms did not recur.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.190.152.109